Skip to main content
logo
Vanda Pharmaceuticals Inc. (VNDA)
NASDAQ: VNDA · Real-Time Price · USD
6.24
-0.14 (-2.19%)
At close: Jul 10, 2026, 4:00 PM EDT
6.20
-0.04 (-0.64%)
After-hours: Jul 10, 2026, 4:05 PM EDT

Vanda Pharmaceuticals Revenue

Vanda Pharmaceuticals had revenue of $51.72M in the quarter ending March 31, 2026, with 3.35% growth. This brings the company's revenue in the last twelve months to $217.78M, up 8.16% year-over-year. In the year 2025, Vanda Pharmaceuticals had annual revenue of $216.11M with 8.72% growth.

Revenue (ttm)
$217.78M
Revenue Growth
+8.16%
P/S Ratio
1.72
Revenue / Employee
$408,597
Employees
533
Market Cap
375.85M

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025216.11M17.33M8.72%
Dec 31, 2024198.77M6.13M3.18%
Dec 31, 2023192.64M-61.74M-24.27%
Dec 31, 2022254.38M-14.30M-5.32%
Dec 31, 2021268.68M20.51M8.27%
Dec 31, 2020248.17M20.98M9.23%
Dec 31, 2019227.19M34.07M17.64%
Dec 31, 2018193.12M28.04M16.98%
Dec 31, 2017165.08M19.07M13.06%
Dec 31, 2016146.02M36.09M32.83%
Dec 31, 2015109.93M59.77M119.16%
Dec 31, 201450.16M16.28M48.05%
Dec 31, 201333.88M1.15M3.52%
Dec 31, 201232.73M1.46M4.66%
Dec 31, 201131.27M-4.44M-12.43%
Dec 31, 201035.71M31.16M685.16%
Dec 31, 20094.55M--
Dec 31, 2008---
Dec 31, 2007---
Dec 31, 2006---
Dec 31, 2005---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Puma Biotechnology227.18M
Enanta Pharmaceuticals69.21M
Fennec Pharmaceuticals51.00M
Abeona Therapeutics14.54M
X4 Pharmaceuticals9.01M
Lyell Immunopharma31.00K
Revenue Rankings

VNDA News

More News